Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 55

1.

Benestent II: back to the future.

Emanuelsson H, van der Giessen WJ, Serruys PW.

J Interv Cardiol. 1994 Dec;7(6):587-92.

PMID:
10155208
2.

Heparin-coated Wiktor stents in human coronary arteries (MENTOR trial). MENTOR Trial Investigators.

Vrolix MC, Legrand VM, Reiber JH, Grollier G, Schalij MJ, Brunel P, Martinez-Elbal L, Gomez-Recio M, Bär FW, Bertrand ME, Colombo A, Brachman J.

Am J Cardiol. 2000 Aug 15;86(4):385-9.

3.

Heparin-coated Palmaz-Schatz stents in human coronary arteries. Early outcome of the Benestent-II Pilot Study.

Serruys PW, Emanuelsson H, van der Giessen W, Lunn AC, Kiemeney F, Macaya C, Rutsch W, Heyndrickx G, Suryapranata H, Legrand V, Goy JJ, Materne P, Bonnier H, Morice MC, Fajadet J, Belardi J, Colombo A, Garcia E, Ruygrok P, de Jaegere P, Morel MA.

Circulation. 1996 Feb 1;93(3):412-22.

4.

Reduction of subacute stent thrombosis (SAT) using heparin-coated stents in a large-scale, real world registry.

Gupta V, Aravamuthan BR, Baskerville S, Smith SK, Gupta V, Lauer MA, Fischell TA.

J Invasive Cardiol. 2004 Jun;16(6):304-10.

PMID:
15155999
5.

Comparison of the heparin coated vs the uncoated Jostent--no influence on restenosis or clinical outcome.

Wöhrle J, Al-Khayer E, Grötzinger U, Schindler C, Kochs M, Hombach V, Höher M.

Eur Heart J. 2001 Oct;22(19):1808-16.

PMID:
11549303
6.

Heparin-coated stents.

Kocsis JF, Llanos G, Holmer E.

J Long Term Eff Med Implants. 2000;10(1-2):19-45. Review.

PMID:
10947628
7.

An Internet-based registry examining the efficacy of heparin coating in patients undergoing coronary stent implantation.

Mehran R, Nikolsky E, Camenzind E, Zelizko M, Kranjec I, Seabra-Gomes R, Negoita M, Slack S, Lotan C.

Am Heart J. 2005 Dec;150(6):1171-6.

PMID:
16338254
9.

Risk factors for stent thrombosis after implantation of sirolimus-eluting stents in diabetic and nondiabetic patients: the EVASTENT Matched-Cohort Registry.

Machecourt J, Danchin N, Lablanche JM, Fauvel JM, Bonnet JL, Marliere S, Foote A, Quesada JL, Eltchaninoff H, Vanzetto G; EVASTENT Investigators.

J Am Coll Cardiol. 2007 Aug 7;50(6):501-8. Epub 2007 Jul 23.

10.

Effects of stent coating on platelets and endothelial cells after intracoronary stent implantation.

Atalar E, Haznedaroğlu I, Aytemir K, Aksöyek S, Ovünç K, Oto A, Ozmen F.

Clin Cardiol. 2001 Feb;24(2):159-64.

11.

A prospective multicentre observational study on the management of patients on oral anticoagulation undergoing coronary artery stenting: rationale and design of the ongoing warfarin and coronary stenting (WAR-STENT) registry.

Rubboli A, Bolognese L, Di Pasquale G, Galvani M, La Vecchia L, Maggioni AP.

J Cardiovasc Med (Hagerstown). 2009 Feb;10(2):200-3. doi: 10.2459/JCM.0b013e3283212f07.

PMID:
19377385
12.

Predictors of improvement in left ventricular function after percutaneous revascularization of occluded coronary arteries: a report from the Total Occlusion Study of Canada (TOSCA).

Dzavik V, Carere RG, Mancini GB, Cohen EA, Catellier D, Anderson TE, Barbeau G, Lazzam C, Title LM, Berger PB, Labinaz M, Teo KK, Buller CE; Total Occlusion Study of Canada Investigators.

Am Heart J. 2001 Aug;142(2):301-8.

PMID:
11479470
13.

Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody-coated stent: a prospective single-center registry in high-risk patients.

Miglionico M, Patti G, D'Ambrosio A, Di Sciascio G.

Catheter Cardiovasc Interv. 2008 Apr 1;71(5):600-4. doi: 10.1002/ccd.21437.

PMID:
18360849
14.

Efficacy of heparin-coated stent in early setting of acute myocardial infarction.

Shin EK, Son JW, Sohn MS, Jin DK, Park GS, Koh KK, Ahn TH, Choi IS.

Catheter Cardiovasc Interv. 2001 Mar;52(3):306-12.

PMID:
11246241
15.

Cost effectiveness of stent implantation versus PTCA: the BENESTENT experience.

Van Hout BA, van der Woude T, de Jaegere PP, van den Brand M, van Es GA, Serruys PW, Morel MA.

Semin Interv Cardiol. 1996 Dec;1(4):263-8.

PMID:
9552520
16.
17.

Endovascular brachytherapy in coronary arteries: the Rotterdam experience.

Coen VL, Knook AH, Wardeh AJ, van der Giessen WJ, De Pan C, Sipkema D, Marijnissen JP, Sabaté M, den Boer A, Serruys PW, Levendag PC.

Cardiovasc Radiat Med. 2000 Jan-Mar;2(1):42-50. Review.

PMID:
11229062
18.

Local delivery of a low molecular weight heparin following stent implantation in the pig coronary artery.

Baumbach A, Oberhoff M, Herdeg C, Lerch M, Schröder S, Meisner C, Rübsamen K, Karsch KR.

Basic Res Cardiol. 2000 Jun;95(3):173-8.

PMID:
10879618
19.

Randomized, blinded trial comparing fondaparinux with unfractionated heparin in patients undergoing contemporary percutaneous coronary intervention: Arixtra Study in Percutaneous Coronary Intervention: a Randomized Evaluation (ASPIRE) Pilot Trial.

Mehta SR, Steg PG, Granger CB, Bassand JP, Faxon DP, Weitz JI, Afzal R, Rush B, Peters RJ, Natarajan MK, Velianou JL, Goodhart DM, Labinaz M, Tanguay JF, Fox KA, Yusuf S; ASPIRE Investigators.

Circulation. 2005 Mar 22;111(11):1390-7.

20.

Silicon Carbide Coating Ñ A Semiconducting Hybrid Design of Coronary Stents Ñ A Feasibility Study.

Heublein B, Pethig K, Elsayed AM.

J Invasive Cardiol. 1998 Jun;10(5):255-262.

PMID:
10762797

Supplemental Content

Support Center